The therapeutic effect of highly malignant triple negative breast cancer (TNBC) is negatively
affected by the formation of tumor cell resistant clone and the severe toxicity of …

Glutamate, as one of the most important carbon sources in the TCA cycle, is central in
metabolic processes that will subsequently influence tumor progression. Several factors can …

Monoclonal antibodies (mAbs) hold promise in treating Parkinson's disease (PD), although
poor delivery to the brain hinders their therapeutic application. In the current study, it is …

Beta-adrenergic blockade has been associated with improved cancer survival in patients
with triple-negative breast cancer (TNBC), but the mechanisms of these effects remain …

Neurotransmitter receptors are increasingly recognized to play important roles in anti-tumor
immunity. The expression of the ion channel N-methyl-D-aspartate receptor (NMDAR) on …

Simple Summary A few types of cancers are currently as challenging and difficult to defeat
as pancreatic ductal adenocarcinoma. Several reasons contribute to the complexity of this …

Tumour metastasis is one of the major factors leading to poor prognosis as well as lower
survival among cancer patients. A number of studies investigating the inhibition of tumour …

Genetic instability can be caused by external factors and may also be associated with
intracellular damage. At the same time, there is a large body of research investigating the …

Fluorescent organic nanoparticles (FONs) are a large family of nanostructures constituted by
organic components that emit light in different spectral regions upon excitation, due to the …

Nerve–cancer crosstalk has gained substantial attention owing to its impact on tumour
growth, metastasis and therapy resistance. Effective therapeutic strategies targeting tumour …